Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 16 de 16
Filter
Add more filters










Publication year range
1.
Leukemia ; 30(11): 2198-2207, 2016 11.
Article in English | MEDLINE | ID: mdl-27118406

ABSTRACT

Adaptive resistance of myeloma to proteasome inhibition represents a clinical challenge, whose biology is poorly understood. Proteasome mutations were implicated as underlying mechanism, while an alternative hypothesis based on low activation status of the unfolded protein response was recently suggested (IRE1/XBP1-low model). We generated bortezomib- and carfilzomib-adapted, highly resistant multiple myeloma cell clones (AMO-BTZ, AMO-CFZ), which we analyzed in a combined quantitative and functional proteomic approach. We demonstrate that proteasome inhibitor-adapted myeloma cells tolerate subtotal proteasome inhibition, irrespective of a proteasome mutation, and uniformly show an 'IRE1/XBP1-low' signature. Adaptation of myeloma cells to proteasome inhibitors involved quantitative changes in >600 protein species with similar patterns in AMO-BTZ and AMO-CFZ cells: proteins involved in metabolic regulation, redox homeostasis, and protein folding and destruction were upregulated, while apoptosis and transcription/translation were downregulated. The quantitatively most upregulated protein in AMO-CFZ cells was the multidrug resistance protein (MDR1) protein ABCB1, and carfilzomib resistance could be overcome by MDR1 inhibition. We propose a model where proteasome inhibitor-adapted myeloma cells tolerate subtotal proteasome inhibition owing to metabolic adaptations that favor the generation of reducing equivalents, such as NADPH, which is supported by oxidative glycolysis. Proteasome inhibitor resistance may thus be targeted by manipulating the energy and redox metabolism.


Subject(s)
Drug Resistance, Neoplasm , Multiple Myeloma/drug therapy , Proteasome Inhibitors/pharmacology , Proteomics , ATP Binding Cassette Transporter, Subfamily B/physiology , Adaptation, Biological , Cell Line, Tumor , Clone Cells , Energy Metabolism , Humans , Multiple Myeloma/pathology , Oxidation-Reduction , Proteasome Endopeptidase Complex/genetics
2.
Cancer Res ; 61(19): 6982-6, 2001 Oct 01.
Article in English | MEDLINE | ID: mdl-11585720

ABSTRACT

The therapeutic potential of cisplatin, one of the most active and widely used anticancer drugs, is severely limited by the occurrence of cellular resistance. In this study, using budding yeast Saccharomyces cerevisiae as a model organism to identify novel drug resistance genes, we found that disruption of the yeast gene SKY1 (serine/arginine-rich protein-specific kinase from budding yeast) by either transposon insertion or one-step gene replacement conferred cellular resistance to cisplatin. Heterologous expression of the human SKY1 homologue SRPK1 (serine/arginine-rich protein-specific kinase) in SKY1 deletion mutant yeast cells restored cisplatin sensitivity, suggesting that SRPK1 is a cisplatin sensitivity gene, the inactivation of which could lead to cisplatin resistance. Subsequently, we investigated the role of SRPK1 in cisplatin sensitivity and resistance in human ovarian carcinoma A2780 cells using antisense oligodeoxynucleotides. Treatment of A2780 cells with antisense oligodeoxynucleotides directed against the translation initiation site of SRPK1 led to down-regulation of SRPK1 protein and conferred a 4-fold resistance to cisplatin. The human SRPK1 gene has not been associated with drug resistance before. Our new findings strongly suggest that SRPK1 is involved in cisplatin-induced cell kill and indicate that SRPK1 might potentially be of importance for studying clinical drug resistance.


Subject(s)
Antineoplastic Agents/pharmacology , Cisplatin/pharmacology , Ovarian Neoplasms/drug therapy , Ovarian Neoplasms/genetics , Protein Serine-Threonine Kinases/physiology , Saccharomyces cerevisiae Proteins , Saccharomyces cerevisiae/drug effects , Down-Regulation , Drug Resistance, Neoplasm/genetics , Female , Gene Expression Regulation, Enzymologic , Gene Expression Regulation, Fungal , Gene Expression Regulation, Neoplastic , Gene Silencing , Humans , Oligonucleotides, Antisense/genetics , Oligonucleotides, Antisense/pharmacology , Ovarian Neoplasms/enzymology , Protein Serine-Threonine Kinases/biosynthesis , Protein Serine-Threonine Kinases/genetics , Saccharomyces cerevisiae/enzymology , Saccharomyces cerevisiae/genetics , Tumor Cells, Cultured
3.
J Med Chem ; 44(2): 245-9, 2001 Jan 18.
Article in English | MEDLINE | ID: mdl-11170634

ABSTRACT

Six related dinuclear trans-platinum complexes, with the formula [[trans-PtCl(2)(NH(3))(L)](2)(mu-H(2)N(CH(2))(n)NH(2))](2+) (L = pyridine, 2-picoline, 4-picoline; n = 4, 6) and chloride or nitrate anions, are compared with known cytotoxic dinuclear compounds (L = NH(3); n = 4, 6) that overcome cisplatin resistance. The cytotoxicity of the compounds was determined in L1210 murine leukemia and L1210/2, a cisplatin-resistant derivative. Unlike the L = NH(3) compounds, the substituted n = 4 compounds are more susceptible toward the resistance mechanisms in L1201/2. The n = 6 compounds, however, have comparable IC(50) values in both cell lines. In general, the substituted compounds are less cytotoxic than their NH(3) counterparts. After incubation with equimolar concentrations, the amount of platinum bound to cellular DNA was determined. The compounds show comparable binding, except for the sterically hindered 2-picoline compounds that bind significantly less. The amounts of platinum bound to DNA do not correlate with the cytotoxicity data. As DNA is considered to be the cellular target of platinum antitumor drugs, structural details of the DNA adducts probably account for the differences in cytotoxic activity.


Subject(s)
Antineoplastic Agents/chemical synthesis , Picolines/chemistry , Platinum Compounds/chemical synthesis , Pyridines/chemistry , Animals , Antineoplastic Agents/chemistry , Antineoplastic Agents/pharmacology , Cisplatin/pharmacology , DNA, Neoplasm/metabolism , Drug Resistance, Neoplasm , Leukemia L1210 , Magnetic Resonance Spectroscopy , Platinum Compounds/chemistry , Platinum Compounds/pharmacology , Spectrophotometry, Atomic , Structure-Activity Relationship , Tumor Cells, Cultured
4.
EMBO J ; 19(23): 6498-507, 2000 Dec 01.
Article in English | MEDLINE | ID: mdl-11101522

ABSTRACT

The nucleotide excision repair machinery can be targeted preferentially to lesions in transcribed sequences. This mode of DNA repair is referred to as transcription-coupled repair (TCR). In yeast, the Rad26 protein, which is the counterpart of the human Cockayne syndrome B protein, is implicated specifically in TCR. In a yeast strain genetically deprived of global genome repair, a deletion of RAD26 renders cells UV sensitive and displays a defect in TCR. Using a genome-wide mutagenesis approach, we found that deletion of the SPT4 gene suppresses the rad26 defect. We show that suppression by the absence of Spt4 is specific for a rad26 defect and is caused by reactivation of TCR in a Rad26-independent manner. Spt4 is involved in the regulation of transcription elongation. The absence of this regulation leads to transcription that is intrinsically competent for TCR. Our findings suggest that Rad26 acts as an elongation factor rendering transcription TCR competent and that its requirement can be modulated by Spt4.


Subject(s)
Cell Cycle Proteins , DNA Repair , Fungal Proteins/physiology , Nuclear Proteins , Saccharomyces cerevisiae Proteins , Schizosaccharomyces pombe Proteins , Transcription, Genetic , Transcriptional Elongation Factors , Antineoplastic Agents, Alkylating/pharmacology , Dose-Response Relationship, Radiation , Fungal Proteins/genetics , Gene Deletion , Gene Library , Genotype , Methyl Methanesulfonate/pharmacology , Models, Biological , Mutagenesis , Open Reading Frames , Plasmids/metabolism , Saccharomyces cerevisiae/genetics , Saccharomyces cerevisiae/physiology , Temperature , Time Factors , Ultraviolet Rays
5.
Mol Pharmacol ; 58(6): 1349-56, 2000 Dec.
Article in English | MEDLINE | ID: mdl-11093773

ABSTRACT

Adenosine A(2B) receptors are known as low-affinity receptors due to their modest-to-negligible affinity for adenosine and prototypic agonists. Despite numerous synthetic efforts, 5'-N-ethylcarboxamidoadenosine (NECA) still is the reference agonist, albeit nonselective for this receptor. In our search for higher affinity agonists, we developed decision schemes to select amino acids for mutation to the corresponding residues in the most homologous, higher affinity, human A(2A) receptor. One scheme exploited knowledge on sequence alignments and modeling data and yielded three residues, V11, L58, and F59, mutation of which did not affect agonist affinity. The second scheme combined knowledge on sequence alignments and mutation data and pointed to Ala12 and Asn273. Mutation of Ala12 to threonine did not affect the affinity for NECA, (R)-N(6)-(phenylisopropyl)adenosine (R-PIA), and 2Cl Ado. The affinity of the N273Y mutant for NECA and R-PIA and for the antagonists xanthine amine congener (XAC), ZM241385, and SCH58261 was also unaltered. However, this mutant had a slightly increased affinity for a 2-substituted adenosine derivative, CGS21680. This prompted us to investigate other 2-substituted adenosines, with selectivity and high affinity for A(2A) receptors. All four compounds tested had improved affinity for the N273Y receptor. Of these, 2-(1-hexynyl)adenosine had submicromolar affinity for the N273Y receptor, 0.18 +/- 0.10 microM, with a 61-fold affinity gain over the wt receptor. In addition, the non-NECA analog (S)-PHP adenosine had an affinity of 1.7 +/- 0.5 microM for the wt receptor. The high affinity of (S)-PHP adenosine for the wt receptor suggests that further modifications at the 2-position may yield agonists with even higher affinity for A(2B) receptors.


Subject(s)
Adenosine/analogs & derivatives , Adenosine/metabolism , Alkynes/metabolism , Receptors, Purinergic P1/metabolism , Amino Acid Sequence , Animals , Asparagine/genetics , Asparagine/metabolism , COS Cells , Cyclic AMP/metabolism , Molecular Sequence Data , Mutation , Point Mutation , Protein Conformation , Purinergic P1 Receptor Agonists , Receptor, Adenosine A2A , Receptor, Adenosine A2B , Receptors, Purinergic P1/genetics , Sequence Homology, Amino Acid , Transfection , Tyrosine/genetics , Tyrosine/metabolism
6.
Biochem Biophys Res Commun ; 268(1): 210-5, 2000 Feb 05.
Article in English | MEDLINE | ID: mdl-10652237

ABSTRACT

We have identified rhp23(+), the ortholog of the Saccharomyces cerevisiae RAD23 and human HHR23A and HHR23B genes, in Schizosaccharomyces pombe and examined its role in cell survival and DNA repair. In S. pombe two repair mechanisms are operative on UV-induced photoproducts, i.e., UV damage repair (UVDR) and nucleotide excision repair (NER). Here we show that Rhp23 is solely involved in NER and study its role in DNA repair in the absence of the UVDR pathway. S. pombe rhp23-deficient cells are sensitive toward UV irradiation, although not as sensitive as complete NER-deficient cells. Furthermore we demonstrate that the residual survival observed in rhp23-deficient cells is NER dependent. Despite this NER-dependent survival, uvde rhp23 double mutants are unable to repair cyclobutane pyrimidine dimers. The inability to remove these photolesions from both DNA strands clearly demonstrates that rhp23(+) is involved in transcription coupled repair as well as global genome repair.


Subject(s)
DNA Repair/genetics , Fungal Proteins/genetics , Genes, Fungal , Saccharomyces cerevisiae Proteins , Schizosaccharomyces pombe Proteins , Schizosaccharomyces/genetics , Amino Acid Sequence , Base Sequence , DNA Primers/genetics , DNA Repair Enzymes , DNA-Binding Proteins/genetics , Gene Expression , Genetic Complementation Test , Humans , Molecular Sequence Data , Mutation , Saccharomyces cerevisiae/genetics , Sequence Homology, Amino Acid , Species Specificity
7.
Nucleic Acids Res ; 27(17): 3410-6, 1999 Sep 01.
Article in English | MEDLINE | ID: mdl-10446227

ABSTRACT

The global genome repair (GGR) subpathway of nucleotide excision repair (NER) is capable of removing lesions throughout the genome. In Saccharomyces cerevisiae the RAD7 and RAD16 genes are essential for GGR. Here we identify rhp7 (+), the RAD7 homolog in Schizosaccharomyces pombe. Surprisingly, rhp7 (+)and the previously cloned rhp16 (+)are located very close together and are transcribed in opposite directions. Upon UV irradiation both genes are induced, reaching a maximum level after 45-60 min. These observations suggest that the genes are co-regulated. Schizo-saccharomyces pombe rhp7 or rhp16 deficient cells are, in contrast to S.cerevisiae rad7 and rad16 mutants, not sensitive to UV irradiation. In S.pombe an alternative repair mechanism, UV damage repair (UVDR), is capable of efficiently removing photolesions from DNA. In the absence of this UVDR pathway both rhp7 and rhp16 deficient cells display an enhanced UV sensitivity. Epistatic analyses show that rhp7 (+)and rhp16 (+)are only involved in NER. Repair analyses at nucleotide resolution demonstrate that both Rhp7 and Rhp16, probably acting in a complex, are essential for GGR in S.pombe.


Subject(s)
DNA-Binding Proteins , Fungal Proteins/genetics , Saccharomyces cerevisiae Proteins , Schizosaccharomyces pombe Proteins , Schizosaccharomyces/genetics , Amino Acid Sequence , Blotting, Northern , Cloning, Molecular , DNA Repair/genetics , Dose-Response Relationship, Radiation , Models, Molecular , Molecular Sequence Data , Promoter Regions, Genetic , Protein Binding , Protein Structure, Tertiary , Sequence Homology, Amino Acid , Time Factors , Transcription, Genetic , Ultraviolet Rays
8.
Mutat Res ; 351(2): 147-55, 1996 Apr 13.
Article in English | MEDLINE | ID: mdl-8622708

ABSTRACT

Mutation spectra at the nucleotide sequence level of five hprt cDNA genes integrated in different genomic positions of a HPRT(-) derivative of the human lymphoblastoid TK6 cell line were compared with each other and with the spectrum of mutations confined to the 657 bp coding region of the endogenous hprt gene in the parental TK6 cells. The mutation rates in these genomic positions vary significantly and also the mutation spectra are different. In each genomic position the majority of mutations are basepair substitutions and deletions. the ratios of which vary among the genomic positions. Although it is likely that the different rates of deletion are to a large extent the net result of different rates of misalignment and repair of these errors in the various genomic positions, for the basepair substitutions it is not possible to deduce which mechanisms have caused these mutations and what causes the differences among the genomic positions. Taken together, the differences in mutation rates and spectra cannot be explained by a single mutagenic process.


Subject(s)
Hypoxanthine Phosphoribosyltransferase/genetics , Mutagenesis , Cell Line , DNA, Complementary/genetics , DNA, Recombinant , Humans , Lymphocytes/cytology , Point Mutation , Sequence Deletion , Stem Cells/cytology
9.
Mutagenesis ; 10(2): 137-43, 1995 Mar.
Article in English | MEDLINE | ID: mdl-7603330

ABSTRACT

A spectrum of 100 mutations in the endogenous hprt gene of the human lymphoblastoid TK6 cell line is presented. The majority of the mutations originates in sequences outside the coding region of the gene. Large deletions are a major cause of inactivation of the hprt gene (57% of the mutants). Mutations in the splice sites that result in several forms of aberrantly spliced mRNA are relatively frequently recovered (16%) compared with mutants containing alterations in the coding region of the hprt gene (27%). The majority, but not all, of the splice mutants contain an alteration in the consensus sequences of the splice sites. A spectrum of mutations in the coding region of the hprt gene enlarged to a total of 42 mutants shows that basepair substitutions predominate (71%) and that small deletions and insertions are less frequently recovered. Basepair substitutions arise slightly more frequently at GC basepairs than at AT basepairs.


Subject(s)
Hypoxanthine Phosphoribosyltransferase/genetics , Mutation , Base Sequence , Cell Line , Codon , Genes , Humans , Molecular Sequence Data
10.
Mutat Res ; 326(1): 131-46, 1995 Jan.
Article in English | MEDLINE | ID: mdl-7528881

ABSTRACT

The influence of the genomic position of a gene on UV-induced mutations was studied in the endogenous hprt gene in human lymphoblastoid TK6 cells and in cell lines derived from TK6 each containing a single copy of a hamster hprt cDNA gene integrated on a retroviral vector in different positions of the human genome. Previous studies showed that the genomic sequences surrounding the integration site influence spontaneous mutagenesis, resulting in a 10-fold difference in mutation rates among the hprt cDNA genes. Here we demonstrate that the genomic positions of three integrated hprt cDNA genes do not influence UV-induced mutagenesis. The mutability by UV irradiation in these cell lines is approximately the same (16.0 x 10(-6) per J/m2). The nature of the UV-induced mutations determined in two of the cell lines containing the integrated hprt cDNA gene (approximately 30 mutants each) was also found not to be different. The endogenous hprt gene in the parental TK6 cells exhibits a significantly lower mutability (2.1 x 10(-6) per J/m2) than the cDNA genes, but the spectrum is very similar. The spectrum in TK6 shows no influence of strand-specific repair and resembles most closely the spectrum obtained by McGregor et al. after irradiation of human cells synchronized in S-phase. This suggests that mutations arising in cells that are in S-phase at the time of irradiation constitute the majority of the mutants in an asynchronous TK6 cell population. We hypothesize that repair in the endogenous hprt gene in TK6 cells is very efficient, removing virtually all lesions before replication takes place except in cells that were in S-phase at the time of irradiation when there is not enough time for repair. Furthermore we suggest that the higher mutability of the integrated hprt cDNA genes compared with the endogenous gene is caused by a less efficient repair in the cDNA genes.


Subject(s)
Genome, Human , Hypoxanthine Phosphoribosyltransferase/genetics , Mutagenesis , Ultraviolet Rays , Animals , Base Sequence , Cell Line , Cell Survival , Cricetinae , DNA, Complementary/drug effects , DNA, Recombinant , Humans , Molecular Sequence Data
11.
Mutagenesis ; 8(5): 399-406, 1993 Sep.
Article in English | MEDLINE | ID: mdl-8231820

ABSTRACT

Mutation induction by UV irradiation was studied in a retroviral vector integrated in one copy per cell at various chromosomal positions. As a mutational target, hamster hprt cDNA was present on the retroviral vector. To minimize the influence of repair we used repair-deficient hamster cells, V-H1 and UV5, as a recipient for the vector. There is no major influence of chromosomal position on UV-induced mutation frequency and spectrum because no statistically significant difference between mutation induction in retroviral cDNA copies integrated at different chromosomal sites was observed. However, a major difference was found in mutation induction between the endogenous hamster hprt gene and the retroviral cDNA copies. Most noticeable was the absence in the cDNA of the strong strand bias for mutation induction, which was reported for the endogenous hprt gene. Our results with the hprt cDNA exclude as a general phenomenon a difference in mutation induction for leading and lagging strand DNA replication, which was proposed as an explanation for this strand bias in the endogenous gene. The similarity of mutation induction in the different retroviral cDNA copies, all directly surrounded by the same DNA sequence elements, together with the marked difference between the mutation induction in the endogenous gene and the cDNA copies may point to an important role of chromatin structure in mutation induction.


Subject(s)
DNA, Complementary/radiation effects , DNA, Recombinant/radiation effects , Hypoxanthine Phosphoribosyltransferase/genetics , Mutagenesis , Ultraviolet Rays/adverse effects , Virus Integration/genetics , Animals , Base Sequence , Cells, Cultured , Chi-Square Distribution , Chromatin/chemistry , Cricetinae , DNA Mutational Analysis , DNA Replication/radiation effects , DNA, Complementary/genetics , DNA, Recombinant/genetics , Genetic Vectors/genetics , Molecular Sequence Data , Point Mutation/genetics , Repetitive Sequences, Nucleic Acid , Retroviridae/genetics , Structure-Activity Relationship
12.
Mutagenesis ; 8(3): 207-20, 1993 May.
Article in English | MEDLINE | ID: mdl-8332083

ABSTRACT

We have studied spontaneous mutagenesis in five hprt cDNA genes integrated at five different genomic positions in a human lymphoblastoid cell line (TK6). The spectra of 40 mutants from each position were combined to obtain a mutation spectrum of the overall genome. This collection of mutants was used to assess the contribution of several mutagenic processes to spontaneous mutagenesis. Deletions and single base pair changes account for the majority of the mutants and arise in approximately equal amounts (43 and 41%, respectively). The majority of the deletions and insertions are < 5 bp and are likely to be caused by template-directed misalignment (slippage) during replication. To account for frameshifts at non-iterated sites we propose a slightly different template-directed replication error model. A considerable amount of the observed base pair changes can also be explained by this last model, but several other processes leading to base pair changes such as depurination, deamination or spontaneously arising DNA damage are likely to contribute as well. We have compared this spectrum with mutation spectra in the endogenous hprt genes using published mutation data. It is shown that in the endogenous genes the contribution of base pair substitutions is much larger (71%) than in the hprt cDNA integrates and that deletions are less frequently observed (20%). The mutation rates of the integrated hprt cDNA genes show a mean increase of 30-fold as compared with the endogenous hprt gene. This results in a 60-fold increase of the absolute rate of deletion in the hprt cDNA genes and in a 15-fold increase of the base pair substitution rate. Replication errors such as slippage or the mechanism proposed in this study probably account to a large extent for this increase.


Subject(s)
Hypoxanthine Phosphoribosyltransferase/genetics , Mutation , Adenine Phosphoribosyltransferase/genetics , Animals , Base Composition , Base Sequence , Cell Line , DNA , DNA Replication , Genome, Human , Humans , Models, Genetic , Molecular Sequence Data , Oligodeoxyribonucleotides , Point Mutation , Sequence Deletion
13.
Hum Mol Genet ; 2(2): 173-82, 1993 Feb.
Article in English | MEDLINE | ID: mdl-8499905

ABSTRACT

We have used five isogenic human lymphoblastoid cell lines each containing a retroviral vector at a different position in the genome to assess the influence of these positions on spontaneous mutagenesis. The vector contains the hamster hprt cDNA and the neo gene, both genes are transcribed from the retroviral LTR promoter. The rates of mutation leading to a HPRT- phenotype during growth in non-selective medium differed up to 60-fold in the five retroviral integrates, ranging from 5.9 x 10(-6) to 3.5 x 10(-4) mutations per cell generation. From each of the cell lines approximately 20 independent mutants were analyzed by Southern blot analysis. In two cell lines all mutations were caused by inactivation of the LTR promoter (presumably by DNA methylation), whereas in another cell line the estimated rate of this mutation is 1000-fold lower. Another important class of mutation is homologous recombination between the LTRs. This accounts for at least half of the mutants in the other three cell lines. Mutants carrying deletions or point mutations form a minor fraction of the mutant distribution. Mutations confined to the hprt cDNA sequences only were studied by selecting HPRT- mutants in the presence of G418. Even for this subset of mutations the rates can vary at least 10-fold between the different genomic positions, ranging from 4.2 x 10(-7) to 5.1 x 10(-6). We conclude therefore that mutations leading to a HPRT- phenotype are quantitatively as well as qualitatively different in the studied cell lines. This suggests that spontaneous mutagenesis in a gene is dependent on its position in the genome.


Subject(s)
DNA, Recombinant/genetics , Genetic Vectors/genetics , Hypoxanthine Phosphoribosyltransferase/genetics , Mutagenesis , Retroviridae/genetics , Virus Integration/genetics , Animals , Cell Line, Transformed , Cricetinae , DNA/genetics , Humans , Lymphocytes , Repetitive Sequences, Nucleic Acid
14.
Mutat Res ; 214(2): 223-32, 1989 Oct.
Article in English | MEDLINE | ID: mdl-2552307

ABSTRACT

A shuttle vector carrying the origin of SV40 replication, the thymidine kinase (tk) gene of herpes simplex virus and the E. coli xanthine guanine phosphoribosyl transferase (gpt) gene has been introduced into human TK- cells. A transformed cell line containing only one stably integrated copy of the shuttle vector was used to study mutations in the introduced tk gene at the molecular level. Without selection for gpt expression, spontaneous TK- mutants arose at a frequency of approximately 10(-4)/generation, and were caused by deletion of plasmid sequences. However, when selection for expression of the gpt gene was applied, the background level of mutations at the tk gene was below 4.10(-6). From this cell line, TK- mutants were obtained after treatment with N-ethyl-N-nitrosourea (ENU). COS fusion appeared to be an efficient method for rescue and amplification of the integrated shuttle vector from the human chromosome. After further amplification and analysis in E. coli, rescued tk genes were easily identified and were shown to be physically unaltered by the rescue procedure. In contrast to rescued tk genes from TK+ cells, those obtained from the ENU-induced TK- mutants were unable to complement thymidine kinase-negative E. coli cells. Two such tk mutations were mapped in E. coli by marker rescue analysis. A GC----AT transition was the cause of both mutations. We show here that plasmid rescue by COS fusion is a reliable system for studying gene mutations in human cells, since no sequence changes occurred in rescued DNA except for the 2 ENU-induced sequence changes.


Subject(s)
DNA/genetics , Genes, Viral , Genes , Mutation , Simplexvirus/genetics , Thymidine Kinase/genetics , Viral Structural Proteins/genetics , Animals , Cell Line , Escherichia coli/enzymology , Escherichia coli/genetics , Genes, Bacterial , Genetic Vectors , Humans , Pentosyltransferases/genetics , Plasmids , Simplexvirus/enzymology , Thymidine Kinase/deficiency
15.
Biochim Biophys Acta ; 1008(1): 62-70, 1989 Jun 01.
Article in English | MEDLINE | ID: mdl-2541785

ABSTRACT

The herpesvirus thymidine kinase (tk) gene integrated in the human cell line, 2.1-a, can be inactivated by limited de novo methylation. All these TK- clones show partial EcoRI digestion of the recognition site (cGAATTCg) in the tk promoter in contrast to complete digestion of this site in the original cell line. Studies on well-defined substrates prepared in vitro showed that methylation of one cytosine in the EcoRI recognition sequence resulted in partial and methylation of both cytosines in severe inhibition of digestion by EcoRI. This characteristic was used to determine whether no, one or both cytosines in the EcoRI site of the tk promoter were methylated in various TK- clones derived from 2.1-a and in TK+ clones re-expressing the gene after 5-azacytidine treatment. A high correlation was found between inactivity of the tk gene and methylation of only one of the two cytosines in the EcoRI recognition site. The results also show that the tk promoter can be active despite the presence of a methylated cytosine.


Subject(s)
Cytosine , Genes, Viral , Genes , Promoter Regions, Genetic , Simplexvirus/genetics , Thymidine Kinase/genetics , Base Sequence , Blotting, Southern , Cell Line , Deoxyribonuclease EcoRI , Humans , Methylation , Molecular Sequence Data , Plasmids , Restriction Mapping , Simplexvirus/enzymology , Transfection
16.
Biochim Biophys Acta ; 1007(2): 215-23, 1989 Mar 01.
Article in English | MEDLINE | ID: mdl-2465779

ABSTRACT

Spontaneous inactivation of integrated thymidine kinase genes was studied in three human cell lines, one with multiple copies and two with a single copy of a transfected shuttle plasmid containing two selectable genes: the HSV tk gene and the Eco gpt gene. Selection for gpt expression prevented the isolation of TK- mutants which are the result of plasmid loss. Under these conditions TK- clones were isolated with a frequency of 5.10(-6) both with the cell line containing 5 or 6 copies of the tk gene and with one of the two cell lines containing one copy of this gene. This inactivity of the tk gene was associated with de novo methylation as the number of HAT-resistant (TK+) clones strongly increased after growth of the TK- derivatives in the presence of the demethylating agent, 5-azacytidine. Digestion with methylation-sensitive restriction enzymes revealed two different patterns of DNA methylation in the genomic DNA of TK- variants. In the TK- derivatives of the cell line containing multiple copies of the tk gene many HpaII restriction sites in the gene copies were insensitive to digestion. These HpaII sites were, however, not methylated in TK- variants of the cell line containing one copy of the plasmid, and methylated CpGs could be detected only with EcoRI which recognizes the cGAATTCg sequence in the tk promoter region. With the other of the two single-copy TK+ cell lines no TK- mutants were obtained, suggesting that the position of a gene in the genome is an important factor in determining the frequency and the extent of de novo methylation. Additionally, we observed that remethylation is an even more efficient process of gene inactivation as TK+ clones reactivated with 5-azacytidine can become TK- again at a 100-fold higher rate than the original TK+ cell line.


Subject(s)
Gene Expression Regulation , Methylation , Simplexvirus/genetics , Thymidine Kinase/genetics , Azacitidine/pharmacology , Cell Line , Cloning, Molecular , Gene Expression Regulation/drug effects , Humans , In Vitro Techniques , Promoter Regions, Genetic , Regulatory Sequences, Nucleic Acid , Selection, Genetic
SELECTION OF CITATIONS
SEARCH DETAIL
...